Policy
FDA鈥檚 landmark decision to phase out animal testing | A new era for drug discovery and human cell models
不良研究所's perspective on the FDA's groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
14.04.2025不良研究所's perspective on the FDA's groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.